I love Paul Fenyves’ essays. He is a practicing internist and that makes him a pragmatist. Like all great internists, he understands risk and benefit, and the times in medicine you need to push hard, and when you must accept things as they are.
The only thing I mildly disagree with him on in this essay is masking kids. My sense is that if you ran 10 cluster RCTs of kids masking: for flu, influenza, RSV, you name it, you will have null results every time. The actual effect is 0. Why do I feel that way: that’s the nature of behavioral interventions and kids. But, his point is also fair: best case scenario the gain is modest. What should that mean for policy?
Hope you enjoy
Vinay Prasad MD MPH
Know Thy Patient
By Paul Fenyves, Cornell University
Throughout the pandemic, the CDC has been out of step with the American patient. This is a call for the CDC to become more aligned with the people it serves.
We all have a “medical personality” — our unique approach to healthcare marked by our worries, our risk tolerance, and our inclination to do more or less.
Both doctors and patients bring their medical personality into the exam room. Good doctors tailor their care to better match their patient’s medical personality. The intensity of medical care, whether to be aggressive or “less-is-more”, should be adjusted within reason to match the patient’s needs and desires.
Some doctors are unable to match the intensity of care to fit the patient. They add a third blood pressure medication without realizing the patient barely takes the first two. Ultimately, the patient becomes frustrated and finds another doctor.
Applying this exam room philosophy to our country’s pandemic response, national public health did not sufficiently align with the American patient, frequently making recommendations that were far too intense for the average American.
I suspect that this “intensity mismatch” led many Americans to ignore the advice of public health. Had we asked for less of the American patient, we might have gotten more in return – more respect for and acceptance of public health recommendations. Two examples:
Childhood Masking: We continue to debate the efficacy of childhood masking. There is no randomized controlled trial to answer this question (and importantly to estimate the effect size), but we do have RCTs in adults showing a modest reduction in transmission.
And like all of you, I have a gut feeling, which was informed by my experiences. For two years, I masked up and shared small exam rooms with coughing Covid patients and never got sick. When I did finally contract Covid in April 2022, I got it the way I get all my respiratory infections: from my kids.
Despite this, my gut also tells me that covering kid’s faces for years on end would negatively impact their social and emotional development. Of course, I’m not ready to run a five year study to prove this. Many Americans seem to share this concern.
For the sake of argument, let’s assume that childhood masking modestly reduces transmission. Was it prudent for the CDC to recommend continuous school masking through February 2022?
We saw that many Americans were opposed to masking kids. And we also saw that many European nations did not mask their school children at all, so the “standard of care” was quite broad.
When you have a broad standard of care, and a patient who is asking for a less intense approach, you should not offer the most aggressive intervention.
Rather than dismiss those concerned as “anti-maskers,” public health might have split the difference, only recommending childhood masks for a few weeks during the times of highest community spread. I suspect most Americans would have obliged, and we could have enjoyed most of the upside with much less downside. By asking for less, we might have gotten more.
Currently, there are some calls to bring back school masking in order to prevent hospitals from becoming overwhelmed by other pediatric respiratory illnesses, namely RSV and influenza. So far, this proposal is not getting much traction even in most pro-mask cities. I suspect this is because just about everyone is done with masks. By overdosing the intervention, the CDC has turned away even many of its adherents.
Pediatric Covid Vaccinations: The American people are not enthusiastic about getting their children vaccinated against Covid. At the time of writing, less than a third of kids 5-11 have completed the primary series, and for kids 2-4 it’s below 5%.
Again, there is a broad standard of care: Germany recommends just a single dose of mRNA vaccine for kids 5-11. Norway makes vaccines available to kids 5-11 without making a recommendation. Denmark only offers vaccines to kids who are at high risk.
In contrast, the CDC recommends all kids five and up get the initial two doses plus a bivalent booster.
Again, we have the American people asking for a less aggressive approach, but the CDC recommending the most aggressive approach. Do we really want the American people to develop a habit of ignoring the CDC’s vaccine recommendations as being “too aggressive?”
Already we are seeing suggestions that Covid vaccine hesitancy might be spilling over into other more essential vaccines. Why not communicate which vaccines are optional and which are critical? By asking for less, we might get more.
Those of us in medicine have all seen doctors who are unable to dial down the intensity to match the patient’s preference. Doctors who add a second cholesterol medication when the patient barely takes the first.
During the Covid pandemic, the CDC has been such a doctor. This is dangerous. When patients become frustrated with a doctor who is unable to meet them where they’re at, they go find a different one.
Please don’t needlessly turn away the American patient.
I think that we now find ourselves in an interesting place in the pandemic. We now understand very clearly the defined vulnerable groups of patients for serious disease -- elderly, obese, especially those with diabetes and immunocompromised. There are rare but serious complications of some of the vaccines in very defined segments of our population. There are clear and serious side-effects of some public health measures --- lockdowns, discouragement (intentional or unintentional) of avoiding or postponing other vaccines, cancer screenings and elective surgeries, masking of children, virtual learning. We should be in a position to make quite targeted recommendations. It makes sense to offer vaccines to those vulnerable and their family members. A 20 year old college student does not really "need" COVID vaccine, especially if previously infected. However, if she has an 18 year old sibling with a history of lung transplantation or a live-in grandparent, then she almost certainly should get a vaccine and/or booster. If a 25 year old male is living alone and hangs out with his peers, he does not "need" a vaccine, especially if he has a verified history of COVID infection or serologic evidence of natural immunity. However, if he is engaged to a woman who finished successful treatment for lymphoma, he should seek out a non-mRNA vaccine as there is a low risk for myocarditis. If he gets the mRNA vaccine, the second dose should be delayed to lessen the chance of myocarditis.
There must be a patient-specific calculation of risk and benefit. When President Biden got COVID, it made sense for him to get paxlovid. However, the White House physician should have considered an "off label" ten day course because of the high prevalence of rebound given the importance of his involvement in the affairs of our country.
When it comes to masking, I am a little more skeptical than Paul about benefits for children. The good evidence of benefit, especially of the paper surgical masks, which were never intended to prevent the transmission of infection from others to the wearer, is really lacking. Masking should likely be optional. There remain stubbornly ignorant members of society that I see every day wearing surgical masks while driving in cars by themselves and/or while walking outside in the park. Education and informed freedom is vital.
As an internist, I, too, understand well the concept of intensity mismatch. I deal in this daily.
Interestingly, VP has mentioned this concept in prior articles and podcasts, although not by this name. Just like some patients have different levels of concern to take an anti-hypertensive, they also have different levels of concern to mask, get vaccinated, and get tested. THESE are the kinds of people included in studies that represent confounding variables for which are unaccounted.
Not only the CDC, but also the FDA, the Biden admin, NEJM, Lancet, MMWR, etc. have all chosen to overlook the keen eye toward rigorous data analysis owed to the American people. My "red pill" moment was when Marion Gruber and Phil Krause voluntarily left the FDA over ethics-violation issues in the form of undue pressure from the White House...after Pfizer's CEO met with Biden.
We need a clean sweep of the positions currently filled by people who intentionally misled us. Unfortunately, that's unlikely. As my grandfather often reminded me, "gub'ment workers are like cockroaches...can't get rid of 'em."